Shuangyi Ren

Dr. Shuangyi Ren


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
CXCong Xia
Cong Xia
YCYantao Cai
Yantao Cai
SRShuangyi Ren
Shuangyi Ren
CXChenglai Xia
Chenglai Xia
The human gut microbiota is associated with the development and progression of colorectal cancer, and manipulation of the gut microbiota is a novel strategy for the prevention and treatment of colorectal cancer. Some bacteria have antitumor activity against colorectal cancer, where specific bacteria can improve the tumor microenvironment, activate immune cells including dendritic cells, helper T cells, natural killer cells, and cytotoxic T cells, and upregulate the secretion of pro-tumor immune cytokines such as interleukin-2 and interferon. In this paper, we summarize some bacteria with potential benefits in colorectal cancer and describe their roles in the tumor microenvironment, demonstrate the application of gut microbes in combination with immunosuppressive agents, and provide suggestions for further experimental studies and clinical practice applications.

13 March 2024 in Human Genetics
Verified
Journal Article
Closed access
PDF file
JLJinjuan Lv
Jinjuan Lv
XLXiaoqian Liu
Xiaoqian Liu
ZSZhiwei Sun
Zhiwei Sun
JGJianfeng Gao
Jianfeng Gao
XYXiaoqi Yu
Xiaoqi Yu
YZYunfei Zuo
Yunfei Zuo

12 February 2022 in Asian Journal of Surgery
Verified
Journal Article
Open access
JPJiahao Pan
Jiahao Pan
BWBo Wang
Bo Wang
ZFZhen Feng
Zhen Feng
ZSZhiwei Sun
Zhiwei Sun
CXCong Xia
Cong Xia
SRShuangyi Ren
Shuangyi Ren
Laparoscopic total mesorectal excision (L-TME) is difficult to perform because of its technical shortcomings in cases of difficult anatomical condition. In such situations, robotic TME (R-TME) tends to be the procedure of choice. This study aimed to compare R-TME and L-TME treatments for mid-low rectal cancer in patients with difficult anatomical conditions. This retrospective single-center study examined data from 01/2019 to 02/2021 of mid-low rectal cancer patients with difficult anatomical conditions. Perioperative data, short-term outcomes, and 2-year oncologic outcomes were compared between groups. The 106 patients were divided into R-TME (n = 56) and L-TME (n = 50). R-TME was associated with a lower diverting ileostomy rate (28.6% vs 50.0%, P = 0.005). R-TME involved a longer operation time (180 min vs 147.5 min, P < 0.001) but a similar procedure time (147.5 min vs 143.5 min, P = 0.110). More patients treated with R-TME experienced mild postoperative pain (33.9% vs 12.0%, P = 0.015) at a much higher cost ([$13740.8 ± 2038.13] vs [$9579.97 ± 2404.22], P < 0.001). The 2-year overall survival and disease-free survival rates were similar between the groups. R-TME, when performed by an experienced surgeon, can reduce the diverting ileostomy rate and relieve postoperative pain without a longer procedure time but at a higher cost. Larger trials of difficult patients with extended follow-up times are expected.

19 January 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YGYuchen Guo
Yuchen Guo
LHLiang He
Liang He
WTWeidong Tong
Weidong Tong
SRShuangyi Ren
Shuangyi Ren
ZCZhaocheng Chi
Zhaocheng Chi
QWQuan Wang
Quan Wang
Background: Robotic-assisted total mesorectal excision (RaTME) may be associated with reduced conversion to an open approach and a higher rate of complete total mesorectal excision (TME); however, studies on its advantages in intersphincteric resection (ISR) are inadequate. Materials and methods: This retrospective multicenter cohort study enroled consecutive patients who underwent RaTME and laparoscopy-assisted total mesorectal excision (LaTME) at four medical centres between January 2020 and March 2023. Propensity score matching (PSM), inverse probability of treatment weight (IPTW), and multivariate logistic regression analyses were performed. The primary outcome was the ISR rate. Secondary outcomes were coloanal anastomosis (CAA), conversion to open surgery, conversion to transanal TME, abdominoperineal resection, postoperative morbidity and mortality within 30 days, and pathological outcomes. Results: Among the 1571 patients, 1211 and 450 underwent LaTME and RaTME, respectively, with corresponding ISR incidences of 5.3% and 8.4% (P=0.024). After PSM and IPTW, RaTME remained associated with higher ISR rates (4.5% versus 9.4%, P=0.022 after PSM; 4.9% versus 9.2, P=0.005 after IPTW). This association remained in multivariate analysis after adjusting for other confounding factors. RaTME was further associated with a higher CAA rate, longer operating time, and higher hospitalization expenses. Conclusions: RaTME may facilitate ISR in middle and low rectal cancers, showing an independent association with a higher ISR incidence, with pathological outcomes and complications comparable to those of LaTME. However, it may also require a longer operating time and incur higher hospitalization expenses.

11 December 2023 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
FGFangliang Guo
Fangliang Guo
ZSZhiwei Sun
Zhiwei Sun
ZWZongheng Wang
Zongheng Wang
JGJianfeng Gao
Jianfeng Gao
JPJiahao Pan
Jiahao Pan
SRShuangyi Ren
Shuangyi Ren
Background: Prolonged postoperative ileus (PPOI) is a common complication after colorectal surgery that increases patient discomfort, hospital stay, and financial burden. However, predictive tools to assess the risk of PPOI in patients undergoing laparoscopic low anterior resection have not been developed. Thus, the purpose of this study was to develop a nomogram to predict PPOI after laparoscopic low anterior resection for rectal cancer. Methods: A total of 548 consecutive patients who underwent laparoscopic low anterior resection for mid­low rectal cancer at a single tertiary medical center were retrospectively enrolled between January 2019 and January 2023. Univariate and multivariate logistic regression analysis was performed to analyze potential predictors of PPOI. The nomogram was constructed using the filtered variables and internally verified by bootstrap resampling. Model performance was evaluated by receiver operating characteristic curve and calibration curve, and the clinical usefulness was evaluated by the decision curve. Results: Among 548 consecutive patients, 72 patients (13.1%) presented with PPOI. Multivariate logistic analysis showed that advantage age, hypoalbuminemia, high surgical difficulty, and postoperative use of opioid analgesic were independent prognostic factors for PPOI. These variables were used to construct the nomogram model to predict PPOI. Internal validation, conducted through bootstrap resampling, confirmed the great discrimination of the nomogram with an area under the curve of 0.738 (95%CI 0.736–0.741). Conclusions: We created a novel nomogram for predicting PPOI after laparoscopic low anterior resection. This nomogram can assist surgeons in identifying patients at a heightened risk of PPOI.

20 December 2023 in Cellular and Molecular Biology
Verified
Journal Article
Open access
PDF file
CCChunlin Chen
Chunlin Chen
QZQianshi Zhang
Qianshi Zhang
BWBo Wang
Bo Wang
YSYang Song
Yang Song
ZFZhen Feng
Zhen Feng
SRShuangyi Ren
Shuangyi Ren
Colorectal cancer (CRC) is one of the most common and lethal malignancies. According to our analysis in the GEPIA database, SPTBN2 was found to be significantly elevated in COAD patients.Western blot also verified this result, and SPTBN2 was highly expressed in two types of colorectal cancer cells, Caco2 and HCT-8. Therefore, we knocked down SPTBN2 to investigate its function in colorectal cancer, and the results of CCK-8 and Transwell assays showed that SPTBN2 deletion inhibited the proliferation, migration and invasion of CRC cells. In addition, we found that SPTBN2 may be a target of miR-214-3p through the staebase database. miR-214-3p inhibitors promote CRC cell proliferation, migration and invasion. And inhibition of SPTBN2 partially reversed the effect of miR-214-3p in CRC. Taken together, we demonstrated that SPTBN2 acts as an important target of miR-214-3p in CRC. Our study lays the foundation for the mechanism of CRC.